MEN10627 [5053]
MEN10627
| SMILES | CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H]2CNC(=O)C[C@@H](NC1=O)C(=O)N[C@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2 |
| InChIKey | CFDNUNSOUUFTQO-JYMVZIKVSA-N |
| Sequence | XLMDWF |
| HELM | PEPTIDE1{[dD].[dW].F.[*C(=O)[C@@H](CN*)N* |$_R2;;;;;;_R3;;_R1$|].L.M}$PEPTIDE1,PEPTIDE1,1:R3-4:R3|PEPTIDE1,PEPTIDE1,6:R2-1:R1$$$ |
Chemical Properties
| Hydrogen bond acceptors | 8 |
| Hydrogen bond donors | 8 |
| Rotatable bonds | 9 |
| Log P | 0.195 |
| Molecular weight (Da) | 760.3 |
| Stereochemistry info | unspecified |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
MEN10627
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0